SCHEMBL31052954

SCHEMBL31052954

COC(=O)CCn1c(=O)c2c(nc(Cl)n2Cc2ccc(Cl)cc2)n(COCC[Si](C)(C)C)c1=O

nearest known ligand 0.42

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ P2RX3 P56373 14/20 0.42
▸ POLB P06746 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18834083 0.86 TRPC5 (0.49) P2RX3CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL16076186 0.85 MAPT (0.43) POLBTSHRALDH1A1CYP1A2CYP3A4
SCHEMBL31052938 0.85 TRPC5 (0.42) P2RX3POLBTSHRALDH1A1CYP1A2
SCHEMBL19505597 0.81 SMN1; SMN2 (0.38) POLBTSHRKDM4EALDH1A1CYP1A2
SCHEMBL19374965 0.79 ADORA3 (0.51) TSHR
SCHEMBL16076175 0.78 ADORA3 (0.50) TSHRCYP1A2CYP2C19
SCHEMBL555591 0.77 HTT (0.52) POLBTSHRALDH1A1CYP1A2CYP3A4
SCHEMBL16027860 0.75 ALDH1A1 (0.48) POLBTSHRKDM4EALDH1A1SMN1; SMN2
SCHEMBL16028981 0.74 ADORA3 (0.40) —
SCHEMBL31052942 0.71 LMNA (0.49) P2RX3POLBKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118373832-B Macrocyclic compound, pharmaceutical composition and application thereof 深圳晶蛋生物医药科技有限公司 2025-01-28 — — CN disclosed
CN-118373832-A Macrocyclic compound, pharmaceutical composition and application thereof 深圳晶蛋生物医药科技有限公司 2024-07-23 — — CN disclosed
Send feedback